Skip to main content

Advertisement

SpringerLink
Log in

Serum insulin-like growth factor-1 levels in patients with pseudoexfoliation syndrome and glaucoma

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Insulin-like growth factor-1 (IGF-1) is altered in several neurodegenerative diseases, the association between serum IGF-1 levels and glaucoma has not been evaluated. This study was designed to evaluate whether serum IGF-1 levels are different in patients with Pseudoexfoliation (PEX) with or without glaucoma. The study was conducted with 110 participants aged 65 years or older who were divided into three groups: group 1, patients with PEX syndrome; group 2, patients with PEX glaucoma; and group 3, participants without PEX or glaucoma. All participants underwent full ophthalmological examination and a detailed medical history was recorded. Patients with known neurodegenerative diseases other than PEX glaucoma were excluded. Serum IGF-1 levels were measured by automated chemiluminescent assay. Groups 1, 2, and 3 included 35, 34, and 41 patients, respectively; there were no differences regarding age, gender, or systemic disease status. There were also no statistically significant differences between the groups in terms of IGF-1 levels, which were 91.7 ± 39.1, 101.1 ± 40.2, and 107.2 ± 43.8 ng/ml for groups 1, 2, and 3, respectively (p = 0.276). Serum IGF-1 levels were similar by gender, the presence of systemic disease, status of diabetes mellitus, and laterality of the PEX material. There was no correlation between the cup-to-disk ratios and IGF-1 levels (r = −0.214, p = 0.223). IGF-1 levels in the circulation did not differ in the presence of PEX syndrome with or without glaucoma. This may indicate that the neurodegenerative process is local rather than systemic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. You QS, Xu L, Wang YX, Yang H, Ma K, Li JJ, Zhang L, Jonas JB (2013) Pseudoexfoliation: normative data and associations: the Beijing eye study. Ophthalmology 120:1551–1558

    Article  PubMed  Google Scholar 

  2. Schlötzer-Schrehardt U, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141:921–937

    Article  PubMed  Google Scholar 

  3. Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S, Yang A, Liebmann J, Ghiso J, Ritch R (2007) Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci 48:1447–1457

    Article  PubMed  Google Scholar 

  4. Ritch R (2014) Ocular and systemic manifestations of exfoliation syndrome. J Glaucoma 23(8 Suppl 1):S1–S8

    Article  PubMed  Google Scholar 

  5. Ekström C, Kilander L (2014) Pseudoexfoliation and Alzheimer’s disease: a population-based 30-year follow-up study. Acta Ophthalmol 92:355–358

    Article  PubMed  Google Scholar 

  6. Salmon WD Jr, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–836

    CAS  PubMed  Google Scholar 

  7. Puche JE, Castilla-Cortázar I (2012) Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med 10:224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ohlsson C, Mohan S, Sjögren K, Tivesten A, Isgaard J, Isaksson O, Jansson JO, Svensson J (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30:494–535

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Arvat E, Broglio F, Ghigo E (2000) Insulin-Like growth factor I: implications in aging. Drugs Aging 16:29–40

    Article  CAS  PubMed  Google Scholar 

  10. Kilani RT, Guilbert L, Lin X, Ghahary A (2007) Keratinocyte conditioned medium abrogates the modulatory effects of IGF-1 and TGF-beta1 on collagenase expression in dermal fibroblasts. Wound Repair Regen 15:236–244

    Article  PubMed  Google Scholar 

  11. Vesti E, Kivela T (2000) Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 19:345–368

    Article  CAS  PubMed  Google Scholar 

  12. Kang JH, Loomis S, Wiggs JL, Stein JD, Pasquale LR (2012) Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts. Ophthalmology 119:27–35

    Article  PubMed  Google Scholar 

  13. Puska PM (2002) Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma—a prospective 10-year follow-up study. J Glaucoma 11:517–524

    Article  PubMed  Google Scholar 

  14. Wang W, He M, Zhou M, Zhang X (2014) Ocular pseudoexfoliation syndrome and vascular disease: a systematic review and meta-analysis. PLoS One 25(9):e92767

    Article  Google Scholar 

  15. Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Naumann GO (2001) Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 73:765–780

    Article  PubMed  Google Scholar 

  16. Zenkel M, Pöschl E, von der Mark K, Hofmann-Rummelt C, Naumann GO, Kruse FE, Schlötzer-Schrehardt U (2005) Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 46:3742–3752

    Article  PubMed  Google Scholar 

  17. Zenkel M, Schlötzer-Schrehardt U (2014) Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome. J Glaucoma 23:48–50

    Article  Google Scholar 

  18. Gartaganis SP, Georgakopoulos CD, Exarchou AM, Mela EK, Lamari F, Karamanos NK (2001) Increased aqueous humor basic fibroblast growth factor and hyaluronan levels in relation to the exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol Scand 79:572–575

    Article  CAS  PubMed  Google Scholar 

  19. Kara S, Yildirim N, Ozer A, Colak O, Sahin A (2014) Matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliation syndrome. Clin Ophthalmol 29(8):305–309

    Article  Google Scholar 

  20. Luppi C, Fioravanti M, Bertolini B et al (2009) Growth factors decrease in subjects with mild to moderate Alzheimer’s disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS). Arch Gerontol Geriatr 49(Suppl 1):173–184

    Article  CAS  PubMed  Google Scholar 

  21. Vardy ER, Rice PJ, Bowie PC, Holmes JD, Grant PJ, Hooper NM (2007) Increased circulating insulin-like growth factor-1 in late-onset Alzheimer’s disease. J Alzheimers Dis 12:285–290

    CAS  PubMed  Google Scholar 

  22. Godau J, Knauel K, Weber K, Brockmann K, Maetzler W, Binder G, Berg D (2011) Serum insulinlike growth factor 1 as possible marker for risk and early diagnosis of Parkinson disease. Arch Neurol 68:925–931

    Article  PubMed  Google Scholar 

  23. Janciauskiene S, Krakau T (2001) Alzheimer’s peptide: a possible link between glaucoma, exfoliation syndrome and Alzheimer’s disease. Acta Ophthalmol Scand 79:328–329

    Article  CAS  PubMed  Google Scholar 

  24. Koliakos GG, Schlötzer-Schrehardt U, Konstas AG, Bufidis T, Georgiadis N, Dimitriadou A (2001) Transforming and insulin-like growth factors in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 239:482–487

    Article  CAS  PubMed  Google Scholar 

  25. Ma J, Guo C, Guo C, Sun Y, Liao T, Beattie U, Lopez FJ, Chen DF, Lashkari K (2015) Transplantation of human neural progenitor cells expressing IGF-1 enhances retinal ganglion cell survival. PLoS One 29(10):e0125695

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Ophthalmology, Ministry of Health, Diskapi Yildirim Beyazit Training and Research Hospital, İrfan Baştuğ Cad., Dışkapı, Ankara, Turkey

    Aysun Sanal Dogan, Naciye Kabatas, Osman Celikay & Canan Gurdal

  2. Departments of Biochemistry, Ministry of Health, Diskapi Yildirim Beyazit Training and Research Hospital, İrfan Baştuğ Cad., Dışkapı, Ankara, Turkey

    Gonul Erden & Abdullah Ercan Arzuhal

Authors
  1. Aysun Sanal Dogan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naciye Kabatas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gonul Erden
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Osman Celikay
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abdullah Ercan Arzuhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Canan Gurdal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aysun Sanal Dogan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dogan, A.S., Kabatas, N., Erden, G. et al. Serum insulin-like growth factor-1 levels in patients with pseudoexfoliation syndrome and glaucoma. Int Ophthalmol 37, 371–375 (2017). https://doi.org/10.1007/s10792-016-0271-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0271-y

Keywords

Search

Navigation